BiotechTubeBiotechTube
Home/Selvita/Michał Bajor
MB

Michał Bajor

Member of the Management Board, Corporate Development Director

Selvita

Therapeutic Areas

Oncology

Selvita Pipeline

DrugIndicationPhase
SEL24 (MEN1703)Acute Myeloid Leukemia (AML)Phase 1/2
SEL120Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndrome (HR-MDS)Phase 1b
SEL201Solid TumorsPre-clinical
SEL313Solid TumorsDiscovery
SEL340MTAP-deleted CancersDiscovery

Leadership Team at Selvita

BS
Bogusław Sieczkowski
Chief Executive Officer (CEO), Co-founder
PP
Paweł Przewięźlikowski
Chief Operating Officer (COO), Co-founder
KB
Krzysztof Brzózka
Chief Scientific Officer (CSO)
MN
Mirosław Nowakowski
Chief Financial Officer (CFO)
MW
Michał Walczak
Chief Business Officer (CBO)
NP
Natalia Piętka
Vice President, Biology
JK
Jacek Kotański
Vice President, Medicinal Chemistry
CB
Christophe Bourdon
Chief Executive Officer, Selvita France
MW
Michał Wójcik
Member of the Supervisory Board, Chairman
MH
Mirosław Han
Member of the Supervisory Board
View full Selvita profile